Skip to main content
. 2016 Dec 20;34(2):495–512. doi: 10.1007/s12325-016-0464-9

Fig. 1.

Fig. 1

Network of evidence for previously untreated or treated melanoma. a Trial ongoing but data are reported; b Non-standard dose, administration, or setting; c Previously treated patients; d NCT identifier not available, data published (Ravaud et al. 2001). GM-CSF granulocyte-macrophage colony-stimulating factor, gp100 glycoprotein peptide vaccine, T-VEC talimogene laherparepvec